Net Cash Provided by (Used in) Financing Activities in USD of GeoVax Labs, Inc. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
GeoVax Labs, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • GeoVax Labs, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $7.91M.
  • GeoVax Labs, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $23.8M, a 485% increase from 2023.
  • GeoVax Labs, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4.06M, a 88.5% decline from 2022.
  • GeoVax Labs, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $35.4M, a 177% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

GeoVax Labs, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $7.91M +$7.91M 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q1 2024 $0 $0 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q1 2023 $0 -$9.23M -100% 01 Jan 2023 31 Mar 2023 10-Q 04 May 2023
Q1 2022 $9.23M -$3.35M -26.6% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q1 2021 $12.6M +$12.3M +4134% 01 Jan 2021 31 Mar 2021 10-Q 27 Apr 2022
Q1 2020 $297K +$59.2K +24.9% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q1 2019 $238K -$402K -62.8% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020
Q1 2018 $640K +$591K +1202% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019
Q1 2017 $49.2K -$189K -79.4% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018
Q1 2016 $238K -$2.44M -91.1% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2016
Q1 2015 $2.68M 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016
Q1 2013 $1.06M -$1.25M -54.1% 01 Jan 2013 31 Mar 2013 10-Q 02 May 2014
Q1 2012 $2.31M 01 Jan 2012 31 Mar 2012 10-Q 01 May 2013

GeoVax Labs, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $23.8M +$19.7M +485% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025
2023 $4.06M -$31.3M -88.5% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025
2022 $35.4M +$22.6M +177% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024
2021 $12.8M +$276K +2.21% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023
2020 $12.5M +$11.1M +775% 01 Jan 2020 31 Dec 2020 10-K 09 Mar 2022
2019 $1.43M -$60.3K -4.04% 01 Jan 2019 31 Dec 2019 10-K 23 Mar 2021
2018 $1.49M -$61.5K -3.97% 01 Jan 2018 31 Dec 2018 10-K 24 Mar 2020
2017 $1.55M +$212K +15.8% 01 Jan 2017 31 Dec 2017 10-K 26 Mar 2019
2016 $1.34M -$1.34M -50% 01 Jan 2016 31 Dec 2016 10-K 26 Mar 2019
2015 $2.68M +$1.81M +207% 01 Jan 2015 31 Dec 2015 10-K 23 Mar 2018
2014 $873K -$2.39M -73.2% 01 Jan 2014 31 Dec 2014 10-K 24 Mar 2017
2013 $3.26M +$950K +41.1% 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2016
2012 $2.31M +$1.9M +471% 01 Jan 2012 31 Dec 2012 10-K 20 Mar 2015
2011 $404K +$835K 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014
2010 -$430K 01 Jan 2010 31 Dec 2010 10-K 30 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.